{"id":10545,"date":"2026-05-23T02:25:00","date_gmt":"2026-05-23T00:25:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=e10d8391ba0d0afb773b5b70f798bff3"},"modified":"2026-05-23T02:25:00","modified_gmt":"2026-05-23T00:25:00","slug":"immunitybio-96-hour-deadline-alert-kahn-swick-foti-llc-reminds-investors-with-losses-in-excess-of-100000-of-deadline-in-class-action-lawsuit-against-immunitybio-inc-ibrx","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=10545","title":{"rendered":"ImmunityBio 96 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against ImmunityBio, Inc. – IBRX"},"content":{"rendered":"

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC<\/a> (\u201cKSF\u201d) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until May 26, 2026<\/span><\/b> to file lead plaintiff applications in a securities class action lawsuit against ImmunityBio<\/a>, Inc. (NasdaqGS: IBRX) (\u201cImmunityBio\u201d or the \u201cCompany\u201d), if they purchased or otherwise acquired the Company\u2019s securities between January 19, 2026 and March 24, 2026, inclusive (the \u201cClass Period\u201d). This action is pending in the United States District Court for the Central District of California.<\/p><\/a><\/a>

\nWhat You May Do<\/b><\/p>

\nIf you purchased securities of ImmunityBio and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email (lewis.kahn@ksfcounsel.com<\/a>), or visit https:\/\/ksfcounsel.com\/cases\/nasdaqgs-ibrx-2\/<\/a> to learn more. If you wish to serve as a lead plaintiff in this class action by overseeing lead counsel with the goal of obtaining a fair and just resolution, you must request this position by application to the Court by May 26, 2026<\/span><\/b>.<\/p>

\nAbout the Lawsuit<\/b><\/p>

\nImmunityBio and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.<\/p>

\nOn March 24, 2026, a warning letter dated March 13, 2026, from the U.S. Food and Drug Administration to CEO Richard Adcock was made public, stating that a television advertisement and podcast misrepresented Anktiva and resulted in its distribution violating the Federal Food, Drug, and Cosmetic Act. The letter also reportedly noted that the violations \u201care concerning from a public health perspective because the promotional communications create a misleading impression that Anktiva, a treatment for a certain type of bladder cancer, can cure and even prevent all cancer.\u201d On this news, the price of ImmunityBio\u2019s shares fell $1.98 per share, or 21%, to close at $7.42 per share on March 24, 2026.<\/p>

\nThe case is Douglas v. ImmunityBio, Inc., et al., <\/i>No. 26-cv-03261.<\/p>

\nAbout Kahn Swick & Foti<\/a>, LLC<\/p>

\nKSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg.<\/p>

\nTOP 10 Plaintiff Law Firms - According to ISS Securities Class Action Services<\/p>

\nTo learn more about KSF, you may visit www.ksfcounsel.com<\/a>.<\/p>

\nCONNECT WITH US: Facebook<\/a> || Instagram<\/a> || YouTube<\/a> || TikTok<\/a> || LinkedIn<\/a><\/p> Contacts<\/b>

\nKahn Swick & Foti, LLC\nLewis Kahn, Managing Partner\nlewis.kahn@ksfcounsel.com<\/a>1-877-515-1850\n1100 Poydras St., Suite 960\nNew Orleans, LA 70163<\/p>","protected":false},"excerpt":{"rendered":"

NEW YORK & NEW ORLEANS–(BUSINESS WIRE)–Kahn Swick & Foti, LLC (\u201cKSF\u201d) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until May 26, 2026 to file lead plaintiff applications in a sec…<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-10545","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/10545","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=10545"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/10545\/revisions"}],"predecessor-version":[{"id":10546,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/10545\/revisions\/10546"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=10545"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=10545"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=10545"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}